Literature DB >> 7505235

Regulation of insulin-like growth factor binding protein secretion by a murine mammary epithelial cell line.

T C Skaar1, C R Baumrucker.   

Abstract

The regulation of insulin-like growth factor binding protein (IGFBP) secretion by mammogenic and lactogenic hormones was investigated in a mouse mammary epithelial cell line (COMMA-D/MME). Cells were grown to confluency on plastic culture plates in serum-containing medium. The confluent cells were exposed to the hormonal treatments in serum-free medium for 6 days. Conditioned medium was collected on Days 5 and 6 and analyzed for IGFBPs by 125I-labeled insulin-like growth factor (IGF)-II ligand blotting and quantified by densitometry. IGFBP data were expressed as absorbance units x millimeters (AUxmm) that were corrected for DNA per well. In basal serum-free media, the COMMA-D/MME cells secreted predominantly IGFBP-3, but also some IGFBP-2. The mammogenic growth factors, IGF-I (13.3 nM) and epidermal growth factor (EGF; 1.7 nM), both stimulated DNA synthesis (P < 0.05); however, their effects on IGFBP-3 secretion differed. IGF-I stimulated IGFBP-3 secretion whereas EGF was inhibitory. In addition, EGF inhibited IGFBP-2 secretion and IGF-I tended to increase it. No interaction was observed between IGF-I and EGF for any of the parameters measured. Three lactogenic hormones (insulin, 154 nM; prolactin, 4.3 nM; and cortisol, 1.4 microM) in all combinations were tested to determine their effects on IGFBP secretion. Insulin stimulated IGFBP-3 secretion and DNA synthesis, but had no effect on IGFBP-2 secretion. Cortisol inhibited IGFBP-3 secretion and DNA synthesis, but increased IGFBP-2 secretion. Prolactin had no effect on any of the parameters examined. In summary, the COMMA-D/MME cells secrete IGFBP-2 and IGFBP-3 in serum-free media. Although the secretion of IGFBP-2 and IGFBP-3 in serum-free media. Although the secretion of IGFBP-2 and IGFBP-3 was regulated by several of the hormones and growth factors tested, no clear distinction was observed between the mammogenic and lactogenic treatments.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505235     DOI: 10.1006/excr.1993.1300

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

Review 1.  Insulin-like growth factors in milk and mammary gland.

Authors:  C G Prosser
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells.

Authors:  Katalin Csanaky; Wolfgang Doppler; Andrea Tamas; Krisztina Kovacs; Gabor Toth; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

3.  Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.

Authors:  Sarah B Vestey; Claire M Perks; Chandan Sen; Caroline J Calder; Jeff M P Holly; Zoe E Winters
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.